QCLS
NASDAQ · Pharmaceuticals
Q/C Technologies Inc
$3.72
-0.04 (-1.06%)
Open$3.82
Previous Close$3.76
Day High$3.82
Day Low$3.67
52W High$33.56
52W Low$2.50
Volume—
Avg Volume352.5K
Market Cap29.53M
P/E Ratio—
EPS$-35.49
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 6.12M | 5.83M | 5.05M |
| Net Income | 729.3K | 769.8K | 662.9K |
| Profit Margin | 11.9% | 13.2% | 13.1% |
| EBITDA | 1.12M | 1.08M | 875.0K |
| Free Cash Flow | 457.4K | 470.8K | 287.5K |
| Rev Growth | +22.0% | +12.4% | +6.3% |
| Debt/Equity | 0.30 | 0.26 | 0.28 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |